Background
==========

Contrast-enhanced ^1^H~2~O T~1~-weighted cardiovascular MRI is usually interpreted using tracer paradigms; e.g., the extra-/intravascular contrast agent (CA) partition coefficient. However, the signal molecule is water, not CA. Consequently, the myocardial extracellular volume fraction (ECV) is underestimated in proportion to its magnitude. Even more importantly, intercompartmental water exchange kinetics are inaccessible. The mean intracellular water molecule lifetime \[tau~i~\] is assumed effectively 0; though it is a fraction of a second. For cylindrical myocytes with mean cytolemmal water permeability coefficient P~W~and diameter d: tau~i~^-1^= 4(P~W~/d). tau~i~^-1^is linearly related to P~W~and to d^-1^. However, P~W~dominates and is itself dominated by active trans-membrane water cycling. Thus, tau~i~^-1^is proportional to the driving cytolemmal ATPase ion pump activity.

Methods
=======

We acquired serial 1.5T T~1~-weighted ^1^H~2~O data from 6 normal human subjects before and after a single bolus 0.15 mmol/kg CA IV injection. The tissue and blood ROIs comprised \~300 LV wall and \~25 LV voxels \[(2 × 2 × 8) mm^3^\]. Hematocrit values allowed R~1p~estimation.

Results
=======

Figure [1](#F1){ref-type="fig"} plots ROI ^1^H~2~O LV wall tissue (R~1t~) vs. corresponding LV plasma (R~1p~) values during the bolus passage \[R~1~≡ T~1~^-1^\]: 3 post-CA points and 1 pre-CA, for one subject. These are fitted with a shutter-speed (SS) two-site-exchange \[2SX\] expression approximating CA extravasation steady-state, \[CA~o~\] = \[CA~p~\] (o, interstitial); the solid curve \[only v~e~and tau~i~varied\]. The extracellular volume fraction v~e~(SS) \[≡ ECV(SS)\] is 0.38. The tracer paradigm (TP) predicts a straight line for the R~1t~R~1p~-dependence, with slope v~e~: the dashed asymptote. In order to fit the non-linear data, the TP straight line must be pivoted down about the origin: this yields ECV(TP) = 0.25, a 34% reduction. SS success is not a fitting goodness issue: the TP line through the data incurs residuals scarcely larger than for the 2SX curve. Crucial is the systematic TP ECV depression, which increases in pathology. Even more important is the SS access to tau~i~- because of the active trans membrane water cycling link to metabolic activity. We obtain tau~i~= 0.34 s for this subject, the first reported for human myocardium \[means in Table [1](#T1){ref-type="table"}\]. (Since \[CA~o~\] \> \[CA~p~\], v~e~and tau~i~are over- and underestimated.) Pixel by-pixel v~e~and tau~i~values allow parametric mapping.

![**SSP fitting of DCE-MRI data collected from normal human heart in vivo**. The points represent data collected at four times: one prior to CA administration, and three post-CA administration. R~1t~is the myocardial tissue ^1^H~2~O R~1~value, and R~1p~is the blood plasma ^1^H~2~O R~1~value calculated for a hematocrit (Hct) of 0.4. The solid curve represents the best SS model fitting to the data with parameters shown in the inset. The dashed asymptotic line is expected for the tracer paradigm.](1532-429X-16-S1-O111-1){#F1}

###### 

\[n = 6\]

  --------- -------------------
  ECV(TP)   0.26 (+/- 0.02)
  ECV(SS)   0.33 (+/- 0.04)
  tau~i~    0.20 (+/- 0.09) s
  --------- -------------------

Conclusions
===========

The first tau~i~metabolic sensitivity hint came in a 2006 perfused ex vivo rat heart study (with other collaborators) finding that (no flow) ischemia increased tau~i~by 56% - from 0.18 to 0.28 s. For control mice tau~i~= 0.19 s, and for a hypertensive mouse model tau~i~= 0.44 s, values have been reported. The very large (132%) tau~i~increase is accompanied by an only 30% d increase; from 20 to 26 μm. These results demonstrate P~W~dominance of tau~i~, and sensitivity to metabolic activity slowing caused by both ischemia and chronic hypertension.
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